Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Eli Lilly

Impersonation and parody: Shitposters satirically mock Elon Musk’s chaotic Twitter takeover

Posting on Twitter has changed since Elon Musk finalized his $44 billion takeover of the micro-blogging platform.

The Conversation

Profit, privacy and online safety: What's at stake with Twitter verification

The past week has seen Twitter announce – and quickly retract – new rules for authenticating user profiles, notably a controversial proposal to offer “blue check” verification to anyone willing to pay $8 a month. New owner Elon Musk, who on Tuesday set November 29 as the scheme’s relaunch date,…

France 24

Balenciaga becomes the first major brand to delete its Twitter account

Fashion house Balenciaga has become the first brand to delete its Twitter account since the Musk acquisition.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

Twitter Prank Spurs Unexpected Scrutiny of Insulin Prices

A Twitter imposter cost a US pharmaceutical giant billions of dollars, but the viral prank triggered another unexpected crisis -- a new wave of scrutiny of the high cost of its insulin. Authentic-looking fake accounts proliferated last week after Twitter rolled out a paid verification service, the latest in a…

Asharq Al-Awsat

Twitter prank spurs unexpected scrutiny of insulin prices

Washington (AFP) - A Twitter imposter cost a US pharmaceutical giant billions of dollars, but the viral prank triggered another unexpected crisis -- a new wave of scrutiny of the high cost of its insulin.

AFP

These Stocks Are Still Feeling The Heat From Elon Musk's Twitter Blue Dumpster Fire

Tesla Inc (NASDAQ: TSLA) CEO Elon Musk kicked off his first week at the helm of Twitter with a bang — but it backfired.<

Benzinga

Eli Lilly's Twitter Fiasco Continues As Drugmaker Reportedly Pulls 'Millions' In Twitter Ads

Eli Lilly reportedly is pulling advertising from Twitter after a fake account promised free insulin in a fiasco that depressed LLY stock.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Biogen Stock Leaps, Eli Lilly Gains As Roche Alzheimer's Drug Trial Falls Short

"While the (trial) results are not what we hoped, we are proud to have delivered a high quality, clear and comprehensive Alzheimer’s dataset to the field," Roche said.

The Street

Elon Musk fans spend £500,000 on GOAT monument in honour of controversial Twitter owner

The world's richest man will be presented with the statue at his Tesla HQ in Austin, Texas, next month

Daily Mirror

Musk says Twitter Blue will ‘probably’ return by the ‘end of next week’ after trolling of companies, celebs by imposters

Pranked companies like Eli Lilly and Lockheed Martin will no doubt be watching closely.

Fortune

Elon Musk Schools Bernie Sanders

The billionaire seized an opportunity to rekindle the beef with the influential politician.

The Street

Pharmaceutical giant Eli Lilly & Co apologises after fake Twitter account says insulin is free as Elon Musk rolls back verification

The incident is among a wave of impersonations that prompted Twitter to make its relaunched premium service unavailable.

ABC News

No, insulin is not free: Eli Lilly is the latest high-profile casualty of Elon Musk’s Twitter verification mess

Eli Lilly shares fell after pranksters using Twitter Blue impersonated it and made a surprising claim—and this might be just the beginning.

Fortune

Patience At The Right Time Made LLY Stock A Swing Trading Winner

Patience is a virtue but knowing the right time to apply it helps make you money.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Pharmaceutical companies’ stocks dive after verified imposter Twitter account claims ‘insulin is free’

Insulin producers Eli Lilly, Novo Nordisk and Sanofi all reported losses during Friday’s trading

Investors Business Daily

Eli Lilly Dives After Fake Twitter Account Promises Free Insulin; Takes Novo Nordisk, Sanofi With It

Twitter's new verification system shook Eli Lilly — leading LLY stock to skid Friday — after a fake account claimed "insulin is free now."

Investors Business Daily

How Amgen Is Closing In On Rivals Novo Nordisk, Eli Lilly With Obesity Drug

Amgen stock jumped Tuesday on a promising update for its potential rival to obesity treatments from Novo Nordisk and Eli Lilly.

Benzinga

Block, Eli Lilly And 2 Other Stocks Insiders Are Selling

The US economy added 261,000 jobs in October, while the unemployment rate increased to 3.7% during the month. Investors, meanwhile, focused on some notable insider trades.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

How Novo Nordisk Is Trying To Lengthen Its Lead In Weight Loss Over Eli Lilly

Novo Nordisk is planning to boost production for weight-loss shot Wegovy as Eli Lilly angles for approval. NVO stock surged Wednesday.

Benzinga

Nasdaq Down 60 Points; Eli Lilly Lowers Earnings Forecast

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 50 points on Tuesday.

Benzinga

Tesla Shifts China Factory Workers To US Plant, Complete European Approval For AstraZeneca's COVID-19 Shot, Tesla Eyes Cybertruck Commercialization Next Year: Top Stories Tuesday, Nov. 1

Bloomberg Tesla Migrates Shanghai Factory Workers To Boost US Plant Production

Investors Business Daily

Why Eli Lilly's Third-Quarter Beat Wasn't Enough To Save Its Outlook

Eli Lilly topped third-quarter expectations Thursday, but cut its 2022 outlook, citing exchange rates and tax law. LLY stock tumbled.

The Street

Eli Lilly Stock Slides As Muted 2022 Outlook Offsets Q3 Earnings Beat

A surging U.S. dollar and increasing generic competition combined for another disappointing outlook for drugmaker Eli Lilly, offsetting stronger-than-expected third quarter earnings.

Investors Business Daily

Dow Jones Reverses Lower After Key Economic Data; Pfizer, Uber Jump On Earnings

The Dow Jones Industrial Average reversed lower Tuesday after key economic data. Pfizer and Uber jumped on earnings results.

Benzinga

Eli Lilly Unusual Options Activity

A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly (NYSE:LLY) we detected 21 strange trades.

1 … 20 21 22 23

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.